Research in this proposal focuses on the four critical steps needed to make a red cell: the specific red cell differentiation signaling (through the erythropoietin receptor), the specific red cell transcription factor (GAGA- 1), the acquisition of the heme and iron needed to make the specific red cell protein, hemoglobin, and the red cell membrane. Project I tests the hypothesis that the three major signaling pathways activated by the erythropoietin receptor (EpoR)-Ras/MAP kinase, hypothesis that the three major signaling pathways activated by the erythropoietin receptor (EpoR)-Ras/MAP kinase, STAT5, and PI-3' kinase/Akt, function in different ways to prevent apoptosis of erythroid progenitors. Knock-in mice will be used to isolate and test individual pathways and to assess the redundancy of the cytoplasmic domains of TpoR, PrlR and EpoR in signaling. Other studies will explore the roles of transcription factor phosphorylation and ras activation in EpoR signaling. Project II investigates the function of GATA-1, the pivotal nuclear regulatory factor for erythroid gene expression and development. Targeted mutagenesis of GATA-1 will assess the importance of N-finger DNA-binding to erythropoiesis, the function of the N-terminal activation domain, and the role of serine phosphorylation. In addition, a newly discovered GATA-1 target gene, ABC-me, which encodes a putative mitochondrial heme transporter, will be studied by gene knockout in mice and mouse erythroleukemia cells, and by isolation of the zebrafish homologue. Project III evaluates a novel iron exporter called ferroportin 1 in the mouse and zebrafish. The function of ferroportin1 in mammal-ian iron metabolism will be tested by targeted gene disruption and by matings of ferroportin1 (-/-) and other iron deficiency overload mice. Genetic screens in zebrafish will identify factors necessary for ferro-portin1 expression adjacent to developing blood-island and will find genes that interact functionally with ferro-portin1. Project IV addresses three questions in red cell membrane biology. The function of the ankyrin-1 regulatory domain and the redundancy of questions in red cell membrane biology. The function of the ankyrin-1 regulatory domain and the redundancy of ankyrins-1 and -3 will be investigated using gene knock-in techniques. A new bIII spectrin, which is located in the Golgi and cytoplasmic vesicles, will be studied to identify the associated vesicles, characterize spectrin-vesicle interactions, and test the consequences of blocking such interactions or disrupting the bIII spectrin gene. In addition, following on test the consequences of blocking such interactions or disrupting the bIII spectrin gene. In addition, following on preliminary evidence that band 3 is involved in erythroid cytokinesis, interactions of band 3 with spindle components or other proteins will be sought using """"""""pull-down"""""""" and two-hybrid assays, and genetic enhancer and suppressor screens in zebrafish. It is anticipated that these studies will provide information of broad interest and importance to our understanding of growth factor signaling, gene regulation, heme and iron transport and the biology of the red cell membrane skeleton.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL032262-20
Application #
6368972
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Thomas, John
Project Start
1983-01-01
Project End
2006-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
20
Fiscal Year
2001
Total Cost
$1,513,119
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Blaser, Bradley W; Zon, Leonard I (2018) Making HSCs in vitro: don't forget the hemogenic endothelium. Blood 132:1372-1378
Kafina, Martin D; Paw, Barry H (2018) Using the Zebrafish as an Approach to Examine the Mechanisms of Vertebrate Erythropoiesis. Methods Mol Biol 1698:11-36
Clement, Kendell; Farouni, Rick; Bauer, Daniel E et al. (2018) AmpUMI: design and analysis of unique molecular identifiers for deep amplicon sequencing. Bioinformatics 34:i202-i210
Liu, Frances D; Tam, Kimberley; Pishesha, Novalia et al. (2018) Improving hematopoietic recovery through modeling and modulation of the mesenchymal stromal cell secretome. Stem Cell Res Ther 9:268
Huang, Nai-Jia; Lin, Ying-Cing; Lin, Chung-Yueh et al. (2018) Enhanced phosphocholine metabolism is essential for terminal erythropoiesis. Blood 131:2955-2966
Schoonenberg, Vivien A C; Cole, Mitchel A; Yao, Qiuming et al. (2018) CRISPRO: identification of functional protein coding sequences based on genome editing dense mutagenesis. Genome Biol 19:169
Lessard, Samuel; Beaudoin, Mélissa; Orkin, Stuart H et al. (2018) 14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblasts. Hum Mol Genet 27:1411-1420
Esrick, Erica B; Bauer, Daniel E (2018) Genetic therapies for sickle cell disease. Semin Hematol 55:76-86
Yien, Yvette Y; Shi, Jiahai; Chen, Caiyong et al. (2018) FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity. J Biol Chem 293:19797-19811
Wattrus, Samuel J; Zon, Leonard I (2018) Stem cell safe harbor: the hematopoietic stem cell niche in zebrafish. Blood Adv 2:3063-3069

Showing the most recent 10 out of 215 publications